Featured Research

from universities, journals, and other organizations

'Signatures' of genetic mutations in colorectal cancer: Discovery may advance diagnosis, treatment

Date:
July 22, 2014
Source:
Vanderbilt University Medical Center
Summary:
A research team has identified protein 'signatures' of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer. The technological tour de force is described as the first integrated "proteogenomic" characterization of human cancer, "will enable new advances" in diagnosing and treating the disease, the scientists concluded.

A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.

The technological tour de force, described in the current issue of the journal Nature as the first integrated "proteogenomic" characterization of human cancer, "will enable new advances" in diagnosing and treating the disease, the scientists concluded.

"It's a first-of-its-kind paper. I think it's a very important advance in the field," said senior author Daniel Liebler, Ph.D., Ingram Professor of Cancer Research and director of the Jim Ayers Institute for Precancer Detection and Diagnosis at the Vanderbilt-Ingram Cancer Center.

The research team, representing Vanderbilt and six other institutions, is part of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), sponsored by the National Cancer Institute of the National Institutes of Health (NIH).

Proteomics is the study of proteins. While many genetic mutations associated with cancer have been identified, it has been more difficult to analyze the structure and function of proteins that actually do cancer's "work." Until now.

The researchers used advanced mass spectrometry techniques to gather proteomic data on 95 human colorectal tumor samples characterized previously by The Cancer Genome Atlas, a federally funded project to identify genetic abnormalities in cancer.

Data analysis was led by first author Bing Zhang, Ph.D., associate professor of Biomedical Informatics. "Integrating the proteomics data with the vast amount of pre-existing genomic data is a daunting task," Zhang said, "however, it is also the key to turn the data into novel insights."

It is a basic biological principle that DNA -- the genetic code -- is "transcribed" into messenger RNA, then "translated" into proteins. Yet the researchers found that abnormalities in the genes or even the RNA of the samples did not necessarily "translate" into abnormal proteins.

Similarly, some sections of chromosomes that were "amplified" in the tumor samples did not result in amplified or increased protein levels.

Those that did, however, produced "striking effects," suggesting that proteomics might help identify and prioritize the most "impactful" genetic abnormalities that could be targets for new diagnostic tests or drug treatments, Liebler said.

The researchers also identified five subtypes of colon cancer based on their protein content, one of which was associated with poor outcomes. Proteomics thus may help identify patients who would benefit most from chemotherapy after surgery.

"Our discovery of proteomic subtypes opens the door to protein-based diagnostics that could potentially identify the bad cancers that need the aggressive therapy," Liebler said. "That's what we're really hot on going forward."

Liebler said that the support of the Ayers Institute, established in 2005 with a $10 million gift from Jim Ayers, chairman of FirstBank in Lexington, Tenn., and his wife Janet Ayers, was critical for building the infrastructure for conducting the research.

"Without the Ayers Institute, we wouldn't have been in a position to even apply for the CPTAC program, to be a part of this at all," Liebler said.

"This is exciting news that appears to have tremendous implications for cancer diagnosis and treatment," said Janet Ayers. "Jim and I extend our congratulations to Dr. Liebler and the team working with the Jim Ayers Institute for Precancer Detection and Diagnosis at the Vanderbilt-Ingram Cancer Center.

"These are the kinds of discoveries we hoped for when the institute was launched just a few years ago," she said. "To start seeing results like this so quickly is extremely rewarding."


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bing Zhang, Jing Wang, Xiaojing Wang, Jing Zhu, Qi Liu, Zhiao Shi, Matthew C. Chambers, Lisa J. Zimmerman, Kent F. Shaddox, Sangtae Kim, Sherri R. Davies, Sean Wang, Pei Wang, Christopher R. Kinsinger, Robert C. Rivers, Henry Rodriguez, R. Reid Townsend, Matthew J. C. Ellis, Steven A. Carr, David L. Tabb, Robert J. Coffey, Robbert J. C. Slebos, Daniel C. Liebler, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D. R. Mani, Philipp Mertins, Karen A. Ketchum, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan J. Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel Chan, Akhilesh Pandey, Ie-Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert C. Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyo, Tao Liu, Jason E. McDermott, Samuel H. Payne, Karin D. Rodland, Richard D. Smith, Paul Rudnick, Michael Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, Daniel C. Liebler, Melinda E. Sanders, Zhiao Shi, Robbert J. C. Slebos, David L. Tabb, Bing Zhang, Lisa J. Zimmerman, Yue Wang, Sherri R. Davies, Li Ding, Matthew J. C. Ellis, R. Reid Townsend. Proteogenomic characterization of human colon and rectal cancer. Nature, 2014; DOI: 10.1038/nature13438

Cite This Page:

Vanderbilt University Medical Center. "'Signatures' of genetic mutations in colorectal cancer: Discovery may advance diagnosis, treatment." ScienceDaily. ScienceDaily, 22 July 2014. <www.sciencedaily.com/releases/2014/07/140722091723.htm>.
Vanderbilt University Medical Center. (2014, July 22). 'Signatures' of genetic mutations in colorectal cancer: Discovery may advance diagnosis, treatment. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/2014/07/140722091723.htm
Vanderbilt University Medical Center. "'Signatures' of genetic mutations in colorectal cancer: Discovery may advance diagnosis, treatment." ScienceDaily. www.sciencedaily.com/releases/2014/07/140722091723.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com
Attacking Superbugs

Attacking Superbugs

Ivanhoe (Oct. 1, 2014) Two weapons hospitals can use to attack superbugs. Scientists in Ireland created a new gel resistant to superbugs, and a robot that can disinfect a room in minutes. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins